Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
11 December, 2017 05:29 IST
Strides Shasun gets USFDA nod for Potassium Citrate ER tablets
Source: IRIS | 12 Sep, 2017, 10.15AM
Comments  |  Post Comment

Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Potassium Citrate Extended-Release Tablets USP, 5 mEq, 10 mEq, and 15 mEq.

According to IMS data, the US market for Potassium Citrate is approximately USD 110 million.

The company will be the second generic player to commercialize the product. The product, which is the first approval for an Extended Release tablet for the company, will be launched immediately.

Potassium Citrate, a urinary alkalinizing agent, is used for preventing certain types of kidney stones. It works by neutralizing some of the acid in the urine, which helps reduce the formation of crystals. 

Shares of the company gained Rs 28.7, or 3.05%, to trade at Rs 970.00. The total volume of shares traded was 46,320 at the BSE (9.58 a.m., Tuesday).



Strides Shasun Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Glenmark Pharma starts trial of investigational immuno-oncology agent GBR 1342 - 08-Dec-2017 10:45
TVS Motor acquires 14.78% stake in Ultraviolette Automotive - 08-Dec-2017 10:18
Emami to acquire 30% stake in Helios Lifestyle - 08-Dec-2017 10:04
Cyient enters into global alliance with EA Tech - 07-Dec-2017 15:35
SSWL expects 11% growth in order book in Q4FY18 - 07-Dec-2017 11:57
Tata Motors reports JLR sales at 52,332 units in Nov'17 - 07-Dec-2017 11:53
Larsen & Tubro bags order worth over Rs 16 bn - 07-Dec-2017 09:47
Bharti Airtel enters into partnership with Intex Tech - 06-Dec-2017 15:12
TVS Motor launches 'TVS Apache RR 310' - 06-Dec-2017 12:46
RInfra wins overseas EPC contracts of over worth Rs 50 bn - 06-Dec-2017 12:40
Suven Life Sciences secures 2 overseas product patents - 06-Dec-2017 10:35
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer